From Medscape Ob/Gyn

American Society for Reproductive Medicine (ASRM) 2021 Scientific Congress

October 17 - 20, 2021; Virtual and Baltimore, Maryland

October 17 - 20, 2021 Virtual and Baltimore, Maryland

Relugolix Combo Effective for Uterine Fibroids Through 1 Year An extension study of the LIBERTY 1 and 2 randomized controlled trials, LIBERTY 3, showed that the drug had efficacy through week 52, with no new safety signals.
Medscape Medical News, Oct 22, 2020
Studies Gauge Toll of Pausing Fertility Treatment During Pandemic The indefinite time frame for resuming treatment when the New York survey was conducted may have been a major source of distress for patients.
Medscape Medical News, Nov 20, 2020
PCOS Tied to Risk for Cardiovascular Disease After Menopause Even controlling for other baseline risk factors for cardiovascular disease, women with PCOS were more like to have earlier cardiovascular events than women without PCOS.
Medscape Medical News, Oct 19, 2020

Medscape Ob/Gyn© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resources